Speakers
--------
N/A
The interest in bispecific and multivalent antibodies has been renewed
because of advances that now allow them to be manufactured in a stable
and reliable manner. This has opened up the field to a multitude of
approaches for creating bispecific antibodies against a variety of
targets. The decision-making process about when a bispecific or
multiclonal approach should be used, and what mechanism is likely to
be the most effective against a given indication, will be discussed.
This format will allow for ample interaction amongst participants so
they can learn new techniques from each other and add to their arsenal
of options, and find out what might work best in their own lab.